Shen Tao, Jia Shengnan, Ding Guoping, Ping Dongnan, Zhou Liangjing, Zhou Senhao, Cao Liping
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Innovation Center for Minimally Invasive Technique and Device, Zhejiang University, Hangzhou, China.
iScience. 2020 Aug 21;23(8):101431. doi: 10.1016/j.isci.2020.101431. Epub 2020 Aug 2.
Immunotherapy in pancreatic ductal adenocarcinoma (PDAC) treatment faces serious challenges, due particularly to the poor immunogenicity. Cancer cell-derived small extracellular vesicles (sEVs) play important roles in damaging the immune system. However, the effects of pancreatic cancer-derived sEVs on T lymphocytes are unknown. Here we investigated changes in phenotypes and signal transduction pathways in sEVs-treated T lymphocytes. We identified the overexpression of immune checkpoint proteins PD-1, PD-L1, CTLA4, and Tim-3 and the enrichment of FOXP3+ Treg cluster in sEVs-treated T lymphocytes by CyTOF. Gene set enrichment analysis revealed that DNA damage response and metabolic pathways might be involved in sEVs-induced Tregs. ATM, AMPK, SIRT1, SIRT2, and SIRT6 were activated sequentially in sEVs-treated T lymphocytes and essential for sEVs-upregulated expressions of FOXO1A, FOXO3A, and FOXP3. Our study reveals the impact and mechanism of pancreatic cancer cell-derived sEVs on T lymphocytes and may provide insights into developing immunotherapy strategies for PDAC treatment.
胰腺导管腺癌(PDAC)治疗中的免疫疗法面临严峻挑战,尤其是由于免疫原性较差。癌细胞衍生的小细胞外囊泡(sEVs)在破坏免疫系统方面发挥着重要作用。然而,胰腺癌衍生的sEVs对T淋巴细胞的影响尚不清楚。在此,我们研究了sEVs处理的T淋巴细胞的表型和信号转导途径的变化。我们通过质谱流式细胞术(CyTOF)鉴定了sEVs处理的T淋巴细胞中免疫检查点蛋白PD-1、PD-L1、CTLA4和Tim-3的过表达以及FOXP3 + Treg簇的富集。基因集富集分析表明,DNA损伤反应和代谢途径可能参与了sEVs诱导的Tregs。在sEVs处理的T淋巴细胞中,ATM、AMPK、SIRT1、SIRT2和SIRT6依次被激活,并且对于sEVs上调FOXO1A、FOXO3A和FOXP3的表达至关重要。我们的研究揭示了胰腺癌细胞衍生的sEVs对T淋巴细胞的影响及其机制,并可能为开发PDAC治疗的免疫疗法策略提供见解。